Cargando…
Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
Experimental studies have been carried out using 5-aminolaevulinic acid (ALA) to induce transient porphyrin photosensitisation for photodynamic therapy (PDT) in a pancreatic cancer model in Syrian golden hamsters. ALA was given either intravenously or orally (in bolus or fractionated doses) with the...
Autores principales: | Regula, J., Ravi, B., Bedwell, J., MacRobert, A. J., Bown, S. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033503/ https://www.ncbi.nlm.nih.gov/pubmed/8054272 |
Ejemplares similares
-
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993) -
Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Loh, C. S., et al.
Publicado: (1992) -
Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996) -
Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994) -
Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.
por: Messmann, H., et al.
Publicado: (1995)